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Abstract
To reinforce Sampson’s theory of retrograde menstruation in the pathogenesis of endometriosis, proof should be pro-
vided that during menstruation endometrial cells are present in peritoneal fluid (PF). We hypothesize that the prevalence
of PF samples containing endometrial cells is higher in patients with endometriosis than in controls without endometriosis
during menstruation. We selected from our biobank PF samples of 17 reproductive-age women with (n ¼ 9) or without
(n ¼ 8) endometriosis who had received a diagnostic laparoscopy for investigation of pain/infertility. Peritoneal fluid had
been collected during laparoscopy in the menstrual phase of the cycle, centrifuged, and the resulting pellet was stored at
80C. About 5-mm sections of frozen PF pellets were stained using the Dako Envision Flex system with primary
antibodies against epithelial cell adhesion molecule (Ep-CAM; endometrial epithelial cells), CD10 (endometrial stromal
cells), prekeratin (epithelial/mesothelial cells), vimentin (endometrial/mesothelial/immune cells), calretinin (mesothelial
cells), and CD68 (macrophages). The PF cells positive for Ep-CAM were detected in 5 of 9 patients with endometriosis
and 6 of 8 controls (P ¼ .62). CD10 stained positively in 6 of the 9 patients with endometriosis and 3 of the 8 controls
(P ¼ .35). Calretinin and prekeratin staining showed the presence of mesothelial cells in all pellets. Vimentin stained
approximately 100% of the PF cells. CD68þ macrophages represented >50% of cells in all pellets. The prevalence of PF
samples containing endometrial epithelial and stromal cells was not higher in patients with endometriosis than in controls
without endometriosis during menstruation. Our findings question the relevance of endometrial cells in PF for the
pathogenesis of endometriosis and support the importance of other mechanisms such as immune dysfunction and/or
endometrial stem cells.
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Introduction
Endometriosis is a benign gynecological disorder characterized
by the growth of endometrial-like tissue outside the uterus.1
The most common hypothesis concerning its origin is Samp-
son’s theory of retrograde menstruation, which states that dur-
ing menstruation endometrial cells and tissue fragments flow
backward through the fallopian tubes into the peritoneal cavity
where they attach and develop into endometriotic lesions.2 This
concept is supported by the observation of an increased pre-
valence of endometriosis in women with menstrual outflow
obstruction3 and by the capacity of menstrual endometrium
to form endometriotic lesions in baboons when seeded in the
peritoneal cavity.4
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Retrograde menstruation has been defined as the presence
of red-stained peritoneal fluid (PF) at the time of menstruation
and is regarded as a physiological phenomenon, occurring in
up to 90% of reproductive-age women with patent tubes.5-7 In
contrast, only 6% to 10% of the general female population
develops endometriosis.1 However, the definition of red-
stained PF as proof of retrograde menstruation may be insuf-
ficient, since red-stained PF has been observed outside the
menstrual period5 and correlates only weakly with the pres-
ence of endometrial cells in PF.8 In the context of endome-
triosis, the presence of endometrial cells in the peritoneal
cavity is more relevant than the observation of bloody PF.9
Furthermore, the presence of endometrial tissue fragments as
opposed to single endometrial cells may be essential due to
their higher adherence capacity and evasion of the immune
system10,11 and their higher ability to form endometriosis-like
lesions.12
The presence of endometrial cells in PF, based on mor-
phology, has been shown to vary significantly between 0%
and 59%,8,13-15 partially due to problems related to accurate
identification of endometrial cells in PF.9 In order to reli-
ably identify endometrial cells, immunological panels for
epithelial, stromal, and mesothelial markers have been
applied, successfully identifying endometrial epithelial cells
during menstruation in PF of both cases with endometriosis
and controls (50%-92%).16,17 However, in a recent study,
our group demonstrated a low prevalence of endometrial
cells in PF during menstruation, as detected by Prep-stain
methodology,9 challenging the concept that retrograde men-
struation is associated with a high number of endometrial
cells floating in PF. It is possible that the low prevalence of
PF endometrial cells was related to limitations of the Prep-
stain technology used in our previous study,9 such as the
type of fixation18 and the limited amount of possible stain-
ings. Therefore, in this study, we cryosectioned PF pellets, a
method that is more representative to obtain the full cellular
content of PF than Prep-stain monolayers, to test the
hypothesis that the prevalence of PF samples containing
endometrial single cells and endometrial fragments (strands
of epithelial cells and clusters of stromal cells) is higher in
women with endometriosis than in controls.
Materials and Methods
Patient Inclusion
Since 1999, a biobank has been developed based on the
collection and storage of samples after signed informed
consent from women undergoing laparoscopic surgery at the
Leuven University Fertility Center (LUFC). For each
patient, detailed clinical information is available in the elec-
tronic file of the patient, including age, cycle phase at sur-
gery, medication use, and a detailed surgery report with
scoring and staging according to the classification of the
American Society for Reproductive Medicine.19 For the cur-
rent study, the electronic biobank database of the LUFC was
searched (April 2013) in order to identify all PF pellet
samples collected at laparoscopy performed during the men-
strual phase of the cycle in patients who were not taking any
hormonal medication at the time of laparoscopy. The search
identified 18 reproductive-age women (range 25-41 years,
demographic data in Table 1) who had received a diagnostic
laparoscopy for investigation of pelvic pain and/or infertility
at UZ Leuven between January 2005 and July 2009 (since
March 2010, PF has no longer routinely been collected dur-
ing laparoscopy in our center).
A total of 15 (83.33%) of the 18 selected patients had bilat-
eral patent fallopian tubes, 2 (11.11%) of the 18 women had 1
patent tube, and 1 (5.56%) patient did not have patent tubes and
was excluded from the study, resulting in a total of 17 patients.
Endometriosis was visually observed during laparoscopy in 9
women, histologically confirmed in 7 of the 9 cases (77.78%),
and classified19 into minimal–mild (n ¼ 5) and moderate–
severe (n ¼ 4) disease. Controls (n ¼ 8) included women with
a normal pelvis (n ¼ 3) or with nonendometriotic pathology
(n ¼ 5: myoma, n ¼ 4; nonendometriotic adhesions, n ¼ 4;
nonendometriotic ovarian cysts, n ¼ 1; parasalpingeal cysts,
n ¼ 2; hydrosalpinx, n ¼ 1).
Peritoneal Fluid Collection
Peritoneal fluid had been aspirated during laparoscopy from the
pouch of Douglas using a 20-mL syringe before any surgical
manipulation and had been centrifuged (centrifuge Eppendorf
5702R, 300 g, 10 minutes; VWR, Haasrode, Belgium). After
washing with phosphate-buffered saline, the supernatant had
been discarded and the resulting pellet had been stored at
80C until analysis.
Table 1. Demographic Characteristics of the Study Population. AQ2
Endometriosis
(n ¼ 9; Stages I-
II,
n ¼ 5; Stages
III-IV, n ¼ 4) Controls (n¼ 8)
Significance
(P)
Age (mean + SD),
years
32.8+ 5.6 32.9 + 5.0 .97
Duration of
infertility (mean
+ SD), months
62.4+ 51.5 41.2+ 45.0 .19
Primary/secondary
infertility, n (%)
7 (77.8%)/1
(11.1%); no
child wish, 1
(11.1%)
5 (62.5%)/3
(37.5%)
.57
Pelvic pain, n (%) 5 (55.6%) 3 (37.5%) .64
Patency of tubes .21
Bilateral
patent tubes
9 (100%) 6 (75%)
Unilateral
patent tube
0 (0%) 2 (25%)
PF volume (mean
+ SD), mL
5.5+ 5.4 10.8 + 7.2 .11
Abbreviations: PF, peritoneal fluid; SD, standard deviation.
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Immunocytochemistry
All frozen PF pellets were embedded in KP Cryocompound
(Klinipath, Olen, Belgium). About 5-mm serial cryostat sec-
tions were prepared and mounted on Leica microsystems
plus slides (Leica Biosystems, Diegem, Belgium). Sections
were made vertically across the cell pellets to allow the
detection of different cell layers possibly emerging after
centrifugation. A total of 195 serial sections were prepared
per pellet to ensure a representative image of its content
(Figure 1). A total of 65 slides (3 sections per slide or total
of 195 sections) were prepared to allow 9 independent
immunocytochemical assessments of a Papanicolaou (Pap)
staining and 6 different monoclonal antibodies (description
below). Sections were fixed with Acetone GPR Rectapur
(VWR) for 10 minutes before being air dried and stored at
20C until staining. Immunocytochemical staining was
performed using a standard protocol. Briefly, sections were
rinsed in EnVision FLEX wash buffer (Dako Belgium NV,
Heverlee, Belgium) before endogenous peroxidases were
blocked with EnVision FLEX peroxidase-blocking reagent
(Dako Belgium NV, Heverlee, Belgium). After being
washed, the slides were incubated for 30 minutes with
ready-to-use primary mouse monoclonal (link) antibodies
(Dako Belgium NV) against epithelial cell adhesion mole-
cule (Ep-CAM, clone Ber-EP4), calretinin (clone DAK-
Calret 1), prekeratin (PK, clone AE1/AE3), CD10 (clone
56C6), and CD68 (clone KP1), followed by another wash-
ing step and an incubation of 30 minutes with Dako EnVi-
sion FLEX/HRP detection reagent (antirabbit/antimouse
HRP-linked secondary antibody; Dako Belgium NV). Incu-
bation times for vimentin (clone V9) staining were 15 min-
utes for both primary and secondary antibodies. Then, the
sections were washed again, and 3,30-diaminobenzidine
chromogen (EnVision FLEX DAB þ Chromogen diluted
in EnVision FLEX Substrate Buffer; Dako Belgium NV)
was added for 10 minutes to develop the immunostaining.
After being rinsed in running tap water, sections were
counterstained with hematoxylin and mounted using a stan-
dard automated protocol (AutoStainer XL-ST5010 Leica;
Leica Biosystems).
A Pap staining was performed using an automated proto-
col on a Coverstainer CS100-10037 (Dako Belgium NV) to
affirm the presence of a sufficient amount of cells in the
PF pellet.
Two types of negative controls were obtained for each pel-
let: omission of primary antibody and addition of an isotype
control instead of primary antibody. A frozen endometrium
biopsy and a frozen peritoneum biopsy were selected as posi-
tive controls for endometrial and mesothelial markers,
respectively. Control biopsies were retrieved from our bio-
bank (80C) and were refrozen in isopentane in liquid
Figure 1. Overview of sectioning procedure. Sectioning was performed in vertical direction. The 7 different stainings (Papanicolaou, epithelial
cell adhesion molecule [Ep-CAM], calretinin [Calret], prekeratin [PK], vimentin [Vim], CD10, and CD68) were successively performed 9 times
per pellet. For the negative controls, the primary antibody was omitted. As an additional negative control, an immunoglobulin G (IgG)-matched
isotype control was used. In total, 65 slides were made per pellet including 195 sections per pellet.
Table 2. Overview of Immunocytochemical Stainings of Different Markers According to Published Data and Comparison With the Current
Study.
Antigen References Endometrial Epithelial Cells Endometrial Stromal Cells Mesothelial Cells Macrophages Lymphocytes
Ep-CAM 9,20 þ    
Calretinin 9,20,21,22  a/þb þ  
Prekeratin 9 þ  þ  
Vimentin 9,23-26 þ þ þ þ þ
CD10 9,27,28  þ   þ
CD68 9    þ 
Abbreviation: Ep-CAM, epithelial cell adhesion molecule.
a In the current study, our selected antibody for calretinin did not stain positive for stromal cells in the control endometrial biopsy, which has also been noted by
Stewart et al.22
b In the literature, calretinin has often been cited as a marker for endometrial stromal cells.9,21
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nitrogen to maintain tissue structure integrity during
cryosectioning.
The selected markers (Table 2)AQ3 are commonly used in effu-
sion cytology and are relevant to identify endometrial epithe-
lial or stromal cells, mesothelial cells, and macrophages in PF.
According to the literature, Ber-Ep4 reacts with the Ep-CAM
and is specific for cells of epithelial20 (and in rare cases
mesothelial) origin.9 Calretinin has been reported as a marker
for mesothelial cells20 and endometrial stromal cells.21 Pre-
keratin is a marker for mesothelial and endometrial epithelial
cells.9 Vimentin stains endometrial stromal, mesothelial, and
immune cells.9 Vimentin is a mesenchymal marker but is also
expressed in mesoderm-derived epithelia, such as the endo-
metrial epithelium.23-26 CD10 is a marker specifically for
endometrial stromal cells but also stains lymphocytes.9,27,28
CD68 is specific for cells with monocyte/macrophage
lineage.9
Data Interpretation
For each PF pellet, all 195 sections were examined by the first
author (D.O.). Samples were considered positive if they exhib-
ited any degree of cytoplasmic staining without nuclear-
specific reactivity and provided that the signal was observed
in at least 2 subsequent sections. As the markers displayed a
cytoplasmic/membrane staining pattern, any nuclear staining
without cytoplasmic reactivity was considered negative. Each
marker was reported as positive or negative. The PF pellets
were defined to be positive for endometrial cells if they were
positive for either Ep-CAM or CD10. Prevalence of samples
containing a certain cell type was determined by dividing the
amount of positive samples by the total amount of samples
(either controls, endometriosis cases, or both). Fragments of
endometrial cells were defined as (1) strands of Ep-CAM-
positive epithelial cells or (2) cell clusters of CD10-positive
stromal cell groups. Slides were evaluated by the first author
(D.O.), and representative slides were reviewed by an experi-
enced and senior pathologist (T.R.) in a blinded fashion. All
Ep-CAM and CD10-stained slides were assessed by the last
author (A.F.), independently from the first author. If assess-
ments between the first and last author did not correspond, the
pathologist (T.R.) was consulted. This happened in 2 of the 17
pellets, once for Ep-CAM and once for CD10 staining. The
pathologist’s decision was always decisive.
Statistical Analysis
Normality was tested with the D’Agostino and Pearson omni-
bus normality test to determine whether parametric or nonpara-
metric tests were to be used in further analyses. Continuous
variables were evaluated using the unpaired t test (age, PF
volume) or Mann-Whitney U test (duration of infertility). A
P value < .05 was considered statistically significant. To com-
pare prevalence data, w2 or Fisher exact test was used. All
statistical analyses were done in GraphPad Prism version 6
(GraphPad Software, San Diego, California).
Ethical Approval
The study protocol was approved by the Commission for Med-
ical Ethics of the Leuven University Hospital Gasthuisberg
(UZ Leuven, Belgium). All patients had signed an informed
consent.
Results
Antibody Specificity for Endometrial and Mesothelial
Cells in Positive Control Biopsies (Endometrium and
Peritoneum)
In the endometrial positive control tissue, Ep-CAM and PK
exclusively stained epithelial cells (Figure 2, Table 2). Vimen-
tin stained both epithelial and stromal cells. CD10 was specific
for endometrial stromal cells, even though staining was faint.
Calretinin failed to stain any cells in the endometrial biopsy.
Macrophages, dispersed in the endometrial stroma, showed
immunoreactivity for CD68.
The normal peritoneum positive control tissue consisted of
connective tissue covered by a mesothelial cell layer. The
biopsy was oriented in order to visualize the mesothelial cell
layer. Although mesothelial cells were negative for Ep-CAM,
CD10, and CD68 (Figure 3, Table 2), they showed weak immu-
noreactivity for calretinin and strong immunoreactivity for PK.
Vimentin was positive in mesothelial cells and the surrounding
connective tissue.
Peritoneal Fluid Pellet Cytology
Table 3 shows a summary of the immunocytochemical data.
Figure 4 displays a representative image of each staining. In all
pellets, the majority of the cells (50%-100%) were positive for
vimentin. CD68 staining indicated the presence of macro-
phages in all PF pellets. Most pellets (14 of the 17) showed
CD68 staining in >50% of the cells. Calretinin staining was
seen in 12 of the 17 pellets, indicating the presence of mesothe-
lial cells. The PK staining, representing the presence of endo-
metrial epithelial cells or mesothelial cells, was overall more
intense than calretinin staining and was detected in all pellets.
In 3 pellets, calretinin was strongly present and overlapped
with Ep-CAM staining for a proportion of the cells.
Tables 3 and 4 and Figure 5 show the results of immunocy-
tochemical staining for endometrial epithelial (Ep-CAM) and
stromal (CD10) cells. The Ep-CAM staining was seen in 11 of
the 17 pellets (5 of the 9 endometriosis and 6 of the 8 controls).
Of the 6 control women showing epithelial cells in the perito-
neal cavity, 3 presented with myoma. Fragments of Ep-CAM-
positive tissue in the form of strands were often seen, except in
1 case and 1 control where only individual positive cells were
detected. CD10 staining was seen in 9 of the 17 pellets (endo-
metriosis, n ¼ 6; controls, n ¼ 3). CD10 staining was found in
clustered cell groups, except in 2 cases with endometriosis.
Figure 5 illustrates the staining patterns of Ep-CAM and
CD10 as individual cells or grouped in fragments in PF pellets.
No significant difference in the prevalence of samples
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Figure 3. Peritoneal biopsy as positive control for mesothelial cell markers. The biopsy was oriented to visualize the mesothelial layer of the
peritoneum (black arrows) and was stained with antibodies against (A) epithelial cell adhesion molecule (Ep-CAM; no positivity), (B) calretinin
(positive in mesothelial cells), (C) prekeratin (PK; positive in mesothelial cells), (D) vimentin (positive in mesothelial cells and surrounding
connective tissue), (E) CD10 (no positivity), and (F) CD68 (no positivity). Scale bars indicate 50 mm (20 magnification).
Figure 2. Endometrial biopsy as positive control for endometrial epithelial and stromal cell markers. The biopsy was stained with antibodies
against (A) epithelial cell adhesion molecule (Ep-CAM; positive for endometrial epithelial cells), (B) calretinin (no positivity), (C) prekeratin (PK;
positive for endometrial epithelial cells), (D) vimentin (positive for endometrial epithelial and stromal cells), (E) CD10 (positive for endometrial
stromal cells), and (F) CD68 (positive for macrophages scattered in the endometrial stroma). Scale bars indicate 50 mm (20 magnification).
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containing cells positive for Ep-CAM and CD10 was found
when comparing cases with endometriosis and controls (P ¼
.62 and P ¼ .35, respectively) or when comparing cases with
endometriosis and the subgroup of controls with a normal
pelvis (P ¼ 1 and P ¼ .18, respectively). Comparing mini-
mal–mild (stages I-II) and moderate–severe (stages III-IV)
endometriosis did not reveal any significant difference in
Ep-CAM (P ¼ .21) or CD10 positivity (P ¼ .52). Overall, the
presence of fragments of endometrial cells (either Ep-CAM or
CD10 positive) was not significantly different between cases
with endometriosis and controls (P ¼ .59).
The Ep-CAM or CD10 staining was present in 13 of the 17
PF pellets (Table 4), but concurrent staining was only observed
in 7 pellets, similarly in women with endometriosis and con-
trols (P ¼ 1).
Discussion
Our study investigated in detail the properties of the PF cell
population using immunocytochemistry. Normal PF contains
mainly macrophages and to a lesser extent mesothelial cells,
lymphocytes, eosinophils, erythrocytes, and mast cells.29-31 In
our study, CD68þ macrophages were the most abundant cell
type in the PF, followed by mesothelial cells positive for PK
and/or calretinin. We could not confirm our hypothesis that the
prevalence of PF samples containing endometrial cells is
higher in patients with endometriosis than in controls. We also
did not find a difference in cell composition (tissue fragments
vs individual cells) between cases with endometriosis and con-
trols. Our data support the concept of retrograde menstruation
as a common phenomenon but could not determine why some
women develop endometriosis and others do not.
Diverging data have been reported on the prevalence of PF
samples containing endometrial cells based on identification by
(1) morphology (0%-59%)8,13-15,32 or (2) immunocytochemis-
try (0%-100%).9,16,17,33-36
In our current study, we report the presence of endometrial
epithelial cells in PF collected during the menstrual cycle phase
in 5 (55.56%) of the 9 cases with endometriosis and 6 (75%) of
the 8 controls and the presence of endometrial stromal cells in 6
(66.67%) of the 9 cases with endometriosis and 3 (37.5%) of
the 8 controls.
The strength of our study is the exclusive selection of PF
pellets collected during menstruation, since we expected the
most distinct difference in the presence of endometrial cells
between cases and controls to occur at this time of the cycle.
Four other studies using immunological methods reported
results from patients in the menstrual phase of the
cycle,9,16,17,33 and none of these studies showed a difference
in the presence of endometrial cells between cases with endo-
metriosis and controls in this cycle phase (summarized in
Table 5).
A second strength of our study is the use of an extended
antibody panel allowing us to distinguish endometrial,
mesothelial, and immune cells (Table 2). Our study is the only
one investigating both the epithelial (Ep-CAM) and stromal
(CD10) component of the endometrial cells, whereas the other
studies focused solely on the epithelial cell type.9,16,17,33
Furthermore, our method of cryosectioning frozen PF pel-
lets is preferred to cell culturing16,33 or preparation of a cell
monolayer9 because it allows investigation of nonadherent,
nonproliferative cells and avoids formalin-based fixation,
which may cause loss of antigenicity.18 Indeed, we found a
higher prevalence of PF samples containing endometrial
epithelial cells compared with the previous report by our
group.9 Cryosectioning was also used by van der Linden
et al17 whose results corresponded with ours, yet our study
specified the serial staining of 195 consecutive sections, ensur-
ing the reliable representation of the entire PF pellet content.
Our study was limited to a small sample size, especially for
subgroup analysis of controls with a normal pelvis or patients
with minimal–mild versus moderate–severe endometriosis.
Overall, our sample size was comparable with the other studies
Table 3. Immunocytochemical Reactivity Patterns for the 6 Different Markers in Peritoneal Fluid Pellets From Women With (n ¼ 9) and
Controls Without (n ¼ 8) Endometriosis.
Control (n ¼ 8)
Endometriosis
(n ¼ 9)
Normal Pelvis
(n ¼ 3)
No Normal Pelvis: Other Benign
Pathology (n ¼ 5)
Total (Normal þ No
Normal Pelvis)
Ep-CAM (endometrial
epithelial cells)
Strands 2/3 3/5 5/8 4/9
Individual cells 0/3 1/5 1/8 1/9
Total 2/3 4/5 6/8 5/9
CD10 (endometrial
stromal cells)
Clustered cells 0/3 3/5 3/8 4/9
Individual cells 0/3 0/5 0/8 2/9
Total 0/3 3/5 3/8 6/9
Calretinin (mesothelial cells) 2/3 5/5 7/8 5/9
Prekeratin (mesothelial/epithelial cells) 3/3 5/5 8/8 9/9
Vimentin (endometrial, mesothelial, immune
cells)
3/3 5/5 8/8 9/9
CD68 (macrophages) 3/3 5/5 8/8 9/9
Abbreviation: Ep-CAM, epithelial cell adhesion molecule.
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investigating PF during the menstrual phase of the cycle
(Table 5). Furthermore, semiquantitative assessment was
impossible due to intra- and interpellet heterogeneity in antigen
reactivity and cell density/number as also reported by Sharpe-
Timms.33 Heterogeneity is to some extent inherent to any cyto-
logical fluid.
The fact that we, and other groups, cannot (1) reliably
associate endometriosis with the presence of endometrial
cells in PF and (2) cannot document a difference between
cases with endometriosis and controls, may have different
origins. First, stem cells rather than the endometrial epithe-
lial/stromal cells present in PF may be the major instigator
Figure 4. Representative images of prekeratin (PF) pellets for the selected markers. Illustration of (A) Papanicolaou (Pap), (B) epithelial cell
adhesion molecule (Ep-CAM), (C) calretinin, (D) prekeratin (PK), (E) vimentin, (F) CD10, (G) CD68, and (H) negative control. Scale bars
indicate 50 mm (20 magnification).
O et al 7
of endometriosis.37 Apart from endogenous endometrial
cells, bone marrow stem cells may contribute to the regen-
eration of endometrium after menstruation.38 These bone
marrow stem cells may cause endometriosis by differentiat-
ing into endometrial cells in ectopic locations.39 Second,
acellular menstrual endometrial supernatant has been able
to induce endometriosis in baboons, indicating the possibil-
ity that endometrial cells in the peritoneal cavity are not
required for the development of endometriosis and that
other substances in menstrual fluid may be involved.40
Third, it may be difficult to document the presence of
free-floating endometrial cells in the PF, because attachment
of endometrial cells to peritoneum may take place within 1
hour according to in vitro data41 or because endometrial
cells may be cleared by the immune system.42 Furthermore,
clearance of endometrial cells by the immune system may
be impaired in women with endometriosis.42
In summary, we agree with other reports that endometrial
cells are present in the PF of both cases and controls, without
obvious difference between cases and controls of the preva-
lence of PF samples containing endometrial cells. In the
future, studies should be performed with larger amounts of
patients in the menstrual phase of the cycle, using adequate
controls without tubal occlusion, implementing immunocyto-
chemical methods and simultaneously investigating retro-
grade menstruation and the alternative theories for the
development of endometriosis. To allow quantification of
endometrial cells, fresh PF samples could be analyzed using
flow cytometry. Further, it is important to note that the detec-
tion of endometrial cells in PF may be due to shedding from
Figure 5. Epithelial cell adhesion molecule (Ep-CAM) and CD10 staining indicating the presence of endometrial epithelial and stromal cells.
Illustration of (A) Ep-CAM positive cell strands, (B) an individual Ep-CAM positive cell, (C) a CD10-positive cell cluster, and (D) an individual
CD10-positive cell. Scale bars indicate 20 mm (40 magnification). Arrows denote single positive cells.
Table 4. Endometrial Markers Ep-CAM and CD10 Did Not Always Appear Concurrently in Peritoneal Fluid of Women With and Without
Endometriosis.
No Ep-CAM or
CD10 Only Ep-CAM Only CD10
Concurrent Ep-CAM and
CD10
Endometriosis (n ¼ 9) n ¼ 2 n ¼ 1 (individual cells) n ¼ 2 (both individual
cells)
n ¼ 4
Control (n ¼ 8) n ¼ 2 n¼ 3 (one of these: individual cells) n ¼ 0 n ¼ 3
Abbreviation: Ep-CAM, epithelial cell adhesion molecule.
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the lesions,33 thereby representing a consequence rather than
a cause of endometriosis.11
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